Approval Delayed, But Janssen/Legend’s Cilta-Cel May Hit Market Just In Time

BMS/Bluebird’s Abecma Approved But Demand Exceeds Supply

 
• By Mandy Jackson
Close up of hourglass clock on a wooden floor
Time will tell if a three-month approval delay is meaningful for cilta-cel • Source: Alamy

More from Manufacturing

More from Business